AG Mednet Introduces Remote, Non-DICOM File Systems for Clinical Trials, Improves Data Quality
Boston, MA – January 21, 2014 – AG Mednet has announced the availability of new capabilities to enable sponsors, CROs and core laboratories to take delivery of electronic trial data into configurable file structures residing either locally or in any of their network shares. This functionality provides higher-quality data and less delays, making it the most efficient method to collect and transfer Holter data, spectral-domain OCT and newer modalities not yet conforming to the DICOM standard.
Now, meta-data can be assigned to non-DICOM modalities and used for configuring, on a per-study basis, structured directories with explicit hierarchies based on the acquired meta-data. This is especially important for:
- Sites participating in AG Mednet-based clinical trials. The assembly and delivery of imaging submissions remains consistent across both DICOM and non-DICOM data sets;
- Sponsors, CROs and core laboratories. Non-DICOM modalities are delivered to a file system-based infrastructure, while DICOM modalities are delivered either to a standard DICOM environment, or the same file system-based infrastructure.
“In combination with our ability to tag and deliver this data not just to DICOM repositories but also to local file systems, we’re providing cardiovascular trials, as well as projects requiring specialized non-DICOM modalities, with a way to ensure higher quality and less delays than other methods,” said Abraham Gutman, President & CEO of AG Mednet.
For more information about AG Mednet, please visit www.agmednet.com.
About AG Mednet
AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 17,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world’s top 20 pharmaceutical, biotech and medical device companies.
AG Mednet Media Contacts:
Dawn Sullivan or Molly Delaney